Lexeo Therapeutics Overview
Lexeo Therapeutics Target Price
Analysts' 12-month price predictions for LXEO.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.37
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-01-13 | H.C. WainwrightMitchell Kapoor | $10 |  128.8% upside |  |
| 2025-12-17 | Raymond James | $25 | 472.1% upside | |
| 2025-12-10 | OppenheimerLeland Gershell | $20 | 357.7% upside | |
| 2025-11-20 | Cantor Fitzgerald | $19 | 334.8% upside | |
| 2025-10-21 | H.C. Wainwright | $13 | 197.5% upside | |
| 2025-10-15 | Guggenheim | $30 | 586.5% upside | |
| 2025-10-07 | Chardan Capital | $17 | 289% upside | |
| 2025-10-07 | H.C. Wainwright | $15 | 243.2% upside | |
| 2025-10-07 | Leerink PartnersMani Foroohar | $20 | 357.7% upside | |
| 2024-06-12 | Robert W. BairdBrian Skorney | $28 | 540.7% upside | |